Avian ("Bird") Flu Stocks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks

NNVC 2.005

-0.2%

12:48 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: - with a K	11/17/2005 11:15:32 AM
	of 428

US reviewing deaths of Tamiflu patients 19 minutes ago WASHINGTON (Reuters) - U.S. regulators have asked Roche AG for more information about the deaths of 12 children who took the flu-fighting drug Tamiflu, saying in a report released on Thursday that the cause of the deaths was "extremely difficult to interpret." The Food and Drug Administration also said it was "concerning" that 32 psychiatric events, such as hallucinations and abnormal behavior, had been reported in children who took Tamiflu, which is in high demand because it is considered to be one of the best defenses against avian flu in people. Most of the reports came from Japan, the FDA said. Roche, in a separate summary posted on the FDA Web site, said, "there is no increase in deaths and neuropsychiatric events in patients on Tamiflu versus influenza patients in general."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next